麻豆传媒

Second-line T-DXd best option in patients with and without intracranial activity, experts says

Also in TTHealthWatch: time from approval to reimbursement for new drugs

Recommendations for short-interval follow-up or biopsy likely a factor

In cancer survivorship, we must address patients' psychological wellness

Meta-analysis shows ICIs also improved pCR rates in HR-positive/HER2-negative disease

But benefit in modeling study accompanied by more false-positive biopsy recommendations

Health news and commentary gathered by 麻豆传媒 staff

A study's 30-year follow-up data provided no new insights into which patients benefit from RT

Researchers suggest unfavorable risk-benefit ratio "disqualifies" it as a staging tool

Colorectal cancer screening accounted for 64% of the total amount

Also in TTHealthWatch: bilateral mastectomy for breast cancer

Findings question interpretation that contralateral cases represent a new primary tumor

Outcomes varied with age

Intervention could help reduce overtreatment